Vivani Medical, INC. (VANI) — 10-K Filings
All 10-K filings from Vivani Medical, INC.. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (3)
-
Vivani Shifts Focus to Obesity Implants, Reports Positive Preclinical Data
— Mar 26, 2026 Risk: high
Vivani Medical, Inc. (VANI) is a clinical-stage biopharmaceutical company focused on developing miniature, ultra long-acting subdermal drug implant candidates u -
Vivani Medical Files 2024 10-K
— Mar 31, 2025 Risk: medium
Vivani Medical, Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Second Sight M -
Vivani Medical, Inc. Files 2023 10-K Report
— Mar 26, 2024 Risk: medium
Vivani Medical, Inc. (VANI) filed a Annual Report (10-K) with the SEC on March 26, 2024. Vivani Medical, Inc. filed its 10-K report for the fiscal year ending D
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX